Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus (NCT03101098) | Clinical Trial Compass
SuspendedNot Applicable
Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus
Stopped: IRB did not approve this study.
South Korea54 participantsStarted 2017-04-10
Plain-language summary
This randomized trial is aimed to investigate the role of retroperitoneal TLH in enlarge uterus.
Who can participate
Age range19 Years – 70 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* absence of pregnancy at the time of presentation
* uterine volume between 12 and 18 weeks of gestation by pelvic examination
* appropriate medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status classification 1 or 2)
Exclusion Criteria:
* any suggestion of malignant uterine or adnexal diseases
* any major medical comorbidities or psychiatric illnesses, which could affect follow-up and/or compliance
* an inability to understand and provide written informed consent.